Enal Drugs Pvt Ltd. - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1990.
1990 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Enal Drugs Pvt Ltd.

Enal Drugs Pvt Ltd., a active private limited company, was established on 27 June 1990 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230TG1990PTC011422. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.27 Cr.

It upholds a compliant status. Employing 132 professional, Its leadership includes Suresh Babu Sunkaraneni (Managing Director), Nikhil Teja Reddy Mandha (Director), Uma Sunkaraneni (Director). Past directors included Suresh Babu Sunkaraneni, Surender Reddy Akavaram, Nikhil Teja Reddy Mandha. It holds ₹0.55 M open charges and ₹39.80 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.D-34 & 35, Phase - I Ida, Jeedimetla, Hyderabad, Telangana, 500055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1990PTC011422

  • Registration Number

    011422

  • Incorporation Date

    27 June 1990

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹7.27 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 7.27 Cr
  • Company Age 35 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 0.55 M
  • Satisfied Charges ₹ 39.80 Cr
  • Revenue Growth **** 7.92%
  • Profit Growth **** -78.85%
  • Ebitda **** 18.16%
  • Net Worth 1.13%
  • Total Assets **** 5.91%
Company report

Enal Drugs Pvt Ltd.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Enal Drugs Pvt Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Enal Drugs Pvt Ltd.?
Current Directors
Name Designation Appointment Date Status
Suresh Babu Sunkaraneni Managing Director 27 Jun 1990 Current
Nikhil Teja Reddy Mandha Director 01 Feb 2024 Current
Uma Sunkaraneni Director 07 Nov 1994 Current
Achyuth Reddy Manne Director 01 Feb 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 28 Mar 2025 Past
Pramod Abcsdd Additional Director 10 Dec 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 28 Mar 2025 Past
Pramod Abcsdd Director 20 Dec 2013 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Enal Drugs.

Enal Drugs Pvt Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 7.92% increase. The company also saw a substantial fall in profitability, with a 78.85% decrease in profit. The company's net worth moved up by a moderate rise of 1.13%.

Enal Drugs revenue growth over time
Enal Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.92%
*******
*******
*******
*******
Revenue from Operations
*******
 8.00%
*******
*******
*******
*******
Total Assets
*******
 5.91%
*******
*******
*******
*******
Profit or Loss
*******
 -78.85%
*******
*******
*******
*******
Net Worth
*******
 1.13%
*******
*******
*******
*******
EBITDA
*******
 18.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Enal Drugs?

In 2023, Enal Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹553,000.00

Satisfied Charges

₹397,982,190.00

Charges Breakdown by Lending Institutions
  • The Hsbc Ltd : 0.06 Cr
Latest Charge Details
Date Lender Amount Status
24 Feb 2000 The Hsbc Ltd ₹0.55 M Open
03 Jan 2023 Others ₹1.04 Cr Satisfied
01 Sep 2022 Hdfc Bank Limited ₹3.41 M Satisfied
26 Apr 2022 Hdfc Bank Limited ₹2.57 M Satisfied
31 Oct 2020 Others ₹1.04 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Enal Drugs?

Enal Drugs has a workforce of 132 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Enal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enal Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Enal Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Enal Drugs Pvt Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Enal Drugs Pvt Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Nikhil Teja Reddy Mandha was appointed as a Director was appointed as a Director on 01 Feb 2024 & has been associated with this company since 2 years 1 month . was recorded as a recent event.

  • Director Appointment

    Achyuth Reddy Manne was appointed as a Director was appointed as a Director on 01 Feb 2024 & has been associated with this company since 2 years 1 month . was recorded as a recent event.

  • Charges

    A charge registered on 07 Aug 2004 via Charge ID 90123267 with State Bank Of India was fully satisfied on 29 Dec 2023. was recorded as a recent event.

  • Charges

    A charge registered on 01 Sep 2022 via Charge ID 100609660 with Hdfc Bank Limited was fully satisfied on 23 Dec 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Enal Drugs Pvt Ltd.?

The CIN of Enal Drugs Pvt Ltd. is U24230TG1990PTC011422.

Where is Enal Drugs Pvt Ltd. headquartered?

Enal Drugs Pvt Ltd. is headquartered at Plot No.D-34 & 35, Phase - I Ida, Jeedimetla, Hyderabad, Telangana, 500055.

When was Enal Drugs Pvt Ltd. incorporated?

Enal Drugs Pvt Ltd. was incorporated on 27 June 1990.

Who are the current directors of Enal Drugs Pvt Ltd.?

The current directors of Enal Drugs Pvt Ltd. are

What is the primary industry of Enal Drugs Pvt Ltd.?

The primary industry of Enal Drugs Pvt Ltd. is Manufacturing.

Is Enal Drugs Pvt Ltd. a listed company?

Enal Drugs Pvt Ltd. is unlisted.

What is the capital structure of Enal Drugs Pvt Ltd.?

The authorized capital of Enal Drugs Pvt Ltd. is ₹10.00 Cr, and the paid-up capital is ₹7.27 Cr.

What is the compliance status of Enal Drugs Pvt Ltd.?

The compliance status of Enal Drugs Pvt Ltd. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available